Skip to content

Model 030-437 Implant Electrode

by Telectronics, Inc.

510(k) K870610

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK870610 Date20 Mar 1987ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Resubmission of Model 030-437 Implant. Electrode
510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 030-437 Implant Electrode is a permanent pacemaker electrode, classified under product code DTB. It is designed for implantation within the cardiovascular system to facilitate cardiac rhythm management by delivering electrical impulses to the heart muscle as part of a pacemaker or defibrillator system.

This device is intended for single-use implantation and is regulated under FDA 510(k) clearance (K870610) as a Class III medical device. It was authorized for use in 1987 and falls under the regulation number 870.3680. The electrode is supplied sterile and intended for use in controlled clinical settings, adhering to standard implantation procedures for cardiac rhythm management devices.

Other devices from Telectronics, Inc.

See all devices from Telectronics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is the Model 030-437 Implant Electrode designed for reuse in clinical settings, or is it intended for single-use only?

    The Model 030-437 Implant Electrode is explicitly intended for single-use implantation only. This is clearly stated in the device description, which specifies it is supplied sterile and meant for use in controlled clinical settings following standard implantation procedures for cardiac rhythm management devices. Reuse is not recommended or supported by the manufacturer.

  • What types of cardiac rhythm management systems can the Model 030-437 Implant Electrode be used with, and how is it positioned within the cardiovascular system?

    The Model 030-437 Implant Electrode is designed to be part of a pacemaker or defibrillator system for cardiac rhythm management. It is intended for implantation within the cardiovascular system to deliver electrical impulses directly to the heart muscle, facilitating proper pacing or defibrillation as needed. The electrode is classified under product code DTB, which aligns with permanent pacemaker electrodes.

  • How is the Model 030-437 Implant Electrode supplied, and what sterility assurances are provided?

    The Model 030-437 Implant Electrode is supplied sterile by the manufacturer, ensuring it meets clinical standards for implantation. Since it is intended for single-use in controlled settings, sterility is a critical aspect of its packaging and handling instructions, as outlined in the device description.

  • What regulatory pathway was followed for the FDA clearance of this device, and when was it originally authorized?

    The Model 030-437 Implant Electrode was authorized through the FDA 510(k) clearance process (K870610) as a Class III medical device, with a decision date of March 20, 1987. It was classified as substantially equivalent (SESE) under the Cardiovascular (CV) advisory committee and falls under regulation number 870.3680. The device was originally authorized in 1987 for use in cardiac rhythm management.